The IMMY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMMY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The IMMY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View IMMY Detailed Price Forecast - CNN Money||View IMMY Detailed Summary - Google Finance|
|View IMMY Detailed Summary - Yahoo! Finance||View IMMY Stock Research & Analysis - Zacks.com|
|View IMMY Trends & Analysis - Trade-Ideas||View IMMY Major Holders - Barrons|
|View IMMY Call Transcripts - NASDAQ||View IMMY Breaking News & Analysis - Seeking Alpha|
|View IMMY Annual Report - CompanySpotlight.com||View IMMY OTC Short Report - OTCShortReport.com|
|View IMMY Fundamentals - TradeKing||View IMMY SEC Filings - Bar Chart|
|View Historical Prices for IMMY - The WSJ||View Performance/Total Return for IMMY - Morningstar|
|View the Analyst Estimates for IMMY - MarketWatch||View the Earnings History for IMMY - CNBC|
|View the IMMY Earnings - StockMarketWatch||View IMMY Buy or Sell Recommendations - MacroAxis|
|View the IMMY Bullish Patterns - American Bulls||View IMMY Short Pain Metrics - ShortPainBot.com|
|View IMMY Stock Mentions - StockTwits||View IMMY Stock Mentions - PennyStockTweets|
|View IMMY Stock Mentions - Twitter||View IMMY Investment Forum News - Investor Hub|
|View IMMY Stock Mentions - Yahoo! Message Board||View IMMY Stock Mentions - Seeking Alpha|
|View Insider Transactions for IMMY - SECform4.com||View Insider Transactions for IMMY - Insider Cow|
|View IMMY Major Holdings Summary - CNBC||View Insider Disclosure for IMMY - OTC Markets|
|View Insider Transactions for IMMY - Yahoo! Finance||View Institutional Holdings for IMMY - NASDAQ|
|View IMMY Stock Insight & Charts - FinViz.com||View IMMY Investment Charts - StockCharts.com|
|View IMMY Stock Overview & Charts - BarChart||View IMMY User Generated Charts - Trading View|
Does Imprimis Pharmaceuticals Inc’s (NASDAQ:IMMY) CEO Salary Compare Well With Others?
Posted on Friday April 20, 2018
Mark Baum took the helm as Imprimis Pharmaceuticals Inc’s (NASDAQ:IMMY) CEO and grew market cap to US$45.45M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial partRead More...
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting
Posted on Tuesday April 10, 2018
New combination topical drops and other cGMP (current good manufacturing practices) formulations will be showcased SAN DIEGO , April 10, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ...
Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation
Posted on Tuesday March 27, 2018
SAN DIEGO, March 27, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY), an ophthalmology-focused pharmaceutical company, today announced it has secured a patent covering the company's innovative MKO (midazolam, ketamine, and ondansetron) Melt® compounded formulation from the US Patent and Trademark office. US Patent 9,918,993 B2 entitled "Pharmaceutical compositions for anesthesiological applications" was issued on March 20, 2018. Imprimis believes that beyond cataract surgery, there are likely more than 100 million annual procedures in the US ranging from dental, obstetric and gynecological, medical imaging procedures (such as MRIs and CAT scans), vasectomies, colonoscopies, dermatological, plastics procedures, orthopedic, otolaryngological, podiatry, emergency room, urology, and psychiatric that may benefit from an IV-free and opioid-free formulation.
Analysis: Positioning to Benefit within Enbridge Energy Management, Imprimis Pharmaceuticals, Hibbett Sports, Glacier, Regis, and Fox Factory Holding — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Monday March 19, 2018
NEW YORK, March 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...